2m 2m 2m 2m 2m 2m 2m
INSTIL BIO (TIL)
NASDAQ
$8.31+$0.08 (+0.96%)
Price as of Jun 03, 2026 4:10 PM EDT- $54.7MMarket Cap
- -76.08%1-Year Change
- BiotechnologyIndustry
INSTIL BIO (TIL)
$8.31+$0.08 (+0.96%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -24.7M +108.97% | -11.8M -70.11% | -39.6M -71.92% | -141.1M +31.52% | |
Depreciation and Amortization Expense | 534,000 -85.21% | 3.6M -24.10% | 4.8M -20.56% | 6.0M +117.55% | |
Total Operating Expenses | 78.6M +6.85% | 73.5M -53.80% | 159.2M -29.71% | 226.5M +45.58% | |
Operating Profit | -78.6M +6.85% | -73.5M -53.80% | -159.2M -29.71% | -226.5M +45.58% | |
Interest Income | 3.9M -44.78% | 7.0M -21.19% | 8.9M +142.57% | 3.7M N/A | |
Interest Expense | -5.8M -35.18% | -9.0M +72.62% | -5.2M +176.63% | -1.9M N/A | |
Interest Income and Expense and Net | -2.0M -1.70% | -2.0M -154.83% | 3.7M +106.38% | 1.8M N/A | |
Total Nonoperating Income and Expense | 212,000 +107.42% | -2.9M +396.70% | -575,000 +1.95% | -564,000 -52.80% | |
Income before Taxes | -78.6M +6.85% | -73.5M -52.88% | -156.1M -30.70% | -225.3M +43.70% | |
Income Taxes | 0 N/A | N/A N/A | 0 +100.00% | -2.1M -5,415.38% | |
Extraordinary Items | 0 -100.00% | 343,000 -87.03% | 2.6M +119.97% | 1.2M N/A | |
Net Income | -71.4M -3.73% | -74.1M -52.50% | -156.1M -30.06% | -223.2M +42.34% | |
Net Income from Continuing Operations Applicable to Common | -71.4M -3.73% | -74.1M -52.50% | -156.1M -30.70% | -225.3M +43.70% | |
Basic EPS and Net Income | -10.70 -6.06% | -11.39 -52.54% | -24.00 +1,295.35% | -1.72 +16.22% | |
Diluted EPS and Net Income | -10.70 -6.06% | -11.39 -52.54% | -24.00 +1,295.35% | -1.72 +16.22% | |
Basic Weighted Average Shares | 6.7M +2.43% | 6.5M +0.10% | 6.5M -94.98% | 129.5M +22.19% | |
Diluted Weighted Average Shares | 6.7M +2.43% | 6.5M +0.10% | 6.5M -94.98% | 129.5M +22.19% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.6M -24.61% | 8.8M -4.24% | 9.2M -78.97% | 43.7M +16.30% | |
Short-Term Investments | N/A N/A | N/A N/A | 141.2M -35.01% | 217.2M -47.85% | |
Cash and Cash Equivalents and Short-Term Investments | 6.6M -24.61% | 8.8M -94.14% | 150.4M -42.37% | 260.9M -42.54% | |
Total Current Assets | 191.4M +53.80% | 124.5M -22.57% | 160.8M -40.32% | 269.4M -41.95% | |
Accumulated Depreciation | 383,000 -91.99% | 4.8M -36.74% | 7.6M -10.95% | 8.5M +184.79% | |
Property and Plant and Equipment and Net | 126,000 -99.90% | 129.4M -6.69% | 138.7M -29.56% | 196.9M +61.38% | |
Total Long-Term Assets | 4.1M -53.57% | 8.8M +1,270.42% | 639,000 -81.28% | 3.4M -58.06% | |
Total Assets | 203.5M -22.78% | 263.6M -19.06% | 325.6M -32.46% | 482.1M -20.96% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 4.8M -38.67% | 7.9M -25.22% | 10.6M -67.80% | 32.8M -20.72% | |
Total Long-Term Debt | 84.8M +0.74% | 84.2M +3.39% | 81.4M +12.55% | 72.3M N/A | |
Total Long-Term Liabilities | 8,000 -90.36% | 83,000 +3.75% | 80,000 -75.90% | 332,000 +1,560.00% | |
Total Liabilities | 89.7M -4.75% | 94.1M -5.68% | 99.8M -15.80% | 118.5M +116.35% | |
Retained Earnings | -726.5M +10.89% | -655.1M +12.76% | -581.0M +36.74% | -424.9M +110.64% | |
Total Stockholders Equity | 113.9M -32.80% | 169.4M -24.97% | 225.8M -37.89% | 363.6M -34.51% | |
Total Shares Outstanding | 6.8M +3.92% | 6.5M +0.34% | 6.5M -95.00% | 130.1M +0.81% | |
Cash Flow | |||||
Cash from Operating Activities | -36.6M -34.25% | -55.7M -32.10% | -82.0M -54.47% | -180.2M +47.51% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 20.7M -75.57% | 84.6M +46.27% | |
Cash from Investing Activities | 25.5M -52.80% | 54.0M +31.23% | 41.1M -64.09% | 114.5M +124.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.3M +315.50% | 1.8M -78.29% | 8.1M -88.76% | 71.9M -81.72% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -30.56% +21.44% | -25.16% -34.89% | -38.65% -5.44% | -40.87% N/A | |
Return on Equity | -50.39% +34.32% | -37.51% -29.17% | -52.96% +9.02% | -48.58% N/A | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 39.53 +150.75% | 15.76 +3.54% | 15.22 +85.31% | 8.22 N/A | |
Cash Ratio | 1.37 +22.91% | 1.12 +28.05% | 0.87 -34.69% | 1.33 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow